000 00992 a2200265 4500
005 20250514042113.0
264 0 _c20021016
008 200210s 0 0 eng d
022 _a0006-3223
024 7 _a10.1016/s0006-3223(01)01353-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScolnick, Edward M
245 0 0 _aDiscovery and development of antidepressants: a perspective from a pharmaceutical discovery company.
_h[electronic resource]
260 _bBiological psychiatry
_cAug 2002
300 _a154-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aCytochrome P-450 CYP2D6
_xmetabolism
650 0 4 _aDrug Industry
650 0 4 _aHumans
650 0 4 _aMental Disorders
_xdrug therapy
773 0 _tBiological psychiatry
_gvol. 52
_gno. 3
_gp. 154-6
856 4 0 _uhttps://doi.org/10.1016/s0006-3223(01)01353-1
_zAvailable from publisher's website
999 _c12065346
_d12065346